Evidence map›Paper›PMID 20224071›Full record

ArticleAmerican journal of respiratory cell and molecular biology2010

Mesenchymal stem cells require MARCKS protein for directed chemotaxis in vitro.

Jeffrey D Miller, Susan M Lankford, Kenneth B Adler, Arnold R Brody

Abstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. A human cell atlas of fetal gene expression.Science (New York, N.Y.) · 2020
    Article
  5. Article
  6. MARCKS and Lung Disease.American journal of respiratory cell and molecular biology · 2019
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Calpain and MARCKS protein regulation of airway mucin secretion.Pulmonary pharmacology & therapeutics · 2012
    Article
  13. Article
  14. Stem cells and cell therapies in lung biology and lung diseases.Proceedings of the American Thoracic Society · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jeffrey D MillerDept. of Molecular Biomedical Sciences, NC State University, Raleigh, 27606, USA.
Susan M Lankford
Kenneth B Adler
Arnold R Brody
North Carolina State University · US

Funding

Mechanism of Oxidant-Induced Respiratory Mucin SecretionR37HL036982 · NHLBI · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI ADLER, KENNETH BRUCE · 2004 to 2013
$4.0M
TNF-alpha to TGF-beta Signal TransductionR01ES006766 · NIEHS · TULANE UNIVERSITY OF LOUISIANA · PI BRODY, ARNOLD RALPH · 1994 to 2008
$2.4M
TGF-B in Interstitial Lung DiseaseR01HL060532 · NHLBI · TULANE UNIVERSITY OF LOUISIANA · PI BRODY, ARNOLD RALPH · 1997 to 2005
$1.9M
NHLBI NIH HHS R01HL060532NHLBI NIH HHS R37HL-36982NIEHS NIH HHS R01ES006766
6 · The paper itself

Abstract

Mesenchymal stem cells (MSCs) reside within tissues such as bone marrow, cord blood, and dental pulp and can differentiate into other mesenchymal cell types. Differentiated MSCs, called circulating fibrocytes, have been demonstrated in human lungs and migrate to injured lung tissue in experimental models. It is likely that MSCs migrate from the bone marrow to sites of injury by following increasing chemokine concentrations. In the present study, we show that primary mouse bone marrow mesenchymal stem cells (BM-MSCs) exhibit directed chemotaxis through transwell inserts toward increasing concentrations of the chemokines complement component 5a, stromal cell-derived factor-1alpha, and monocyte chemotactic protein-1. Prior research has indicated that myristoylated alanine-rich C kinase substrate (MARCKS) protein is critically important for motility in macrophages, neutrophils, and fibroblasts, and here we investigated a possible role for MARCKS in BM-MSC directed chemotaxis. The presence of MARCKS in these cells as well as in human cord blood MSC was verified by Western blotting, and MARCKS was rapidly phosphorylated in these cells after exposure to chemokines. A synthetic peptide that inhibits MARCKS function attenuated, in a concentration-dependent manner, directed chemotaxis of BM-MSCs, while a missense control peptide had no effect. Our results illustrate, for the first time, that MARCKS protein plays an integral role in BM-MSC-directed chemotaxis in vitro.

Indexed as

AnimalsBlotting, WesternBone Marrow CellsCell DifferentiationCell MovementCells, CulturedChemokine CCL2Chemokine CXCL12ChemotaxisComplement C5aDose-Response Relationship, DrugFetal BloodFibroblastsHumansIntracellular Signaling Peptides and ProteinsIn Vitro TechniquesChemokine CCL2Chemokine CXCL12Complement C5aIntracellular Signaling Peptides and ProteinsMARCKS protein, humanMarcks protein, mouseMembrane ProteinsMyristoylated Alanine-Rich C Kinase SubstratePeptide Fragments

Identifiers

PMID20224071
PMCPMC3159077
OpenAlexW2144513020

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.